dc.contributor.author | Onuk, Ö. | |
dc.contributor.author | Arslan, B. | |
dc.contributor.author | Gezmis, T.C. | |
dc.contributor.author | Çetin, B. | |
dc.contributor.author | Göv, T. | |
dc.contributor.author | Yazıcı, G. | |
dc.contributor.author | Gürkan, O. | |
dc.contributor.author | Ozdemir, E. | |
dc.date.accessioned | 2021-12-21T08:41:03Z | |
dc.date.available | 2021-12-21T08:41:03Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 3011623 | |
dc.identifier.uri | https://doi.org/10.1007/s11255-018-1946-2 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1301 | |
dc.description.abstract | Purpose: The aim of our study was to assess the correlation between serum endocan level and erectile dysfunction (ED). Methods: A total of 92 patients were reviewed in this study after institutional review board approval. The patients’ characteristics wer | |
dc.language.iso | English | |
dc.publisher | Springer Netherlands | |
dc.title | Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction? | |
dc.type | Article | |
dc.relation.journal | International Urology and Nephrology | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 1577 | |
dc.identifier.endpage | 1582 | |
dc.identifier.volume | 50 | |
dc.identifier.doi | 10.1007/s11255-018-1946-2 | |
dc.relation.issue | 9 | |
dc.relation.volume | 50 | |